[Clinical-biochemical evaluation of the therapeutic effects of vitohepatit in acute viral hepatitis].
D000293:Adolescent; D000328:Adult; D000596:Amino Acids / Q000627:therapeutic use*; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006506:Hepatitis A / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D009711:Nucleotides / Q000627:therapeutic use*; D012313:RNA / Q000627:therapeutic use*; D012256:Riboflavin / Q000627:therapeutic use; D014805:Vitamin B 12 / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use*
D000596:Amino Acids; D004338:Drug Combinations; D009539:Nicotinic Acids; D009711:Nucleotides; D014815:Vitamins; D012313:RNA; D014805:Vitamin B 12; D012256:Riboflavin
Kliniko-biokhimicheskaia otsenka lechebnogo deĭstviia vitogepata pri ostrom virusnom gepatite